{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:26:52Z","timestamp":1774362412447,"version":"3.50.1"},"reference-count":25,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background Distribution of COVID-19 vaccines has been surrounded by suspicions and rumors making it necessary to provide the public with accurate reports from trustworthy experts such as healthcare professionals. Methods We distributed a questionnaire in Jordan among physicians, dentists and nurses who received a COVID-19 vaccine to explore the side effects (SE) they encountered after the first or the second dose of one of three vaccines namely: AstraZeneca Vaxzevria (AZ), Pfizer-BioNTeck (PB), and SinoPharm (SP) vaccines. Results A total of 409 professionals participated. Approximately 18% and 31% of participants reported no SE after the first dose and second dose, respectively. The remainder had mostly local side effects related to injection site (74%). Systemic side effects in the form of fatigue (52%), myalgia (44%), headache (42%), and fever (35%) prevailed mainly after the first dose. These were significantly associated with AZ vaccine, and age \u2264 45 years (p = 0.000 and 0.01, respectively). No serious SE were reported. Conclusions We can conclude that SE of COVID-19 vaccines distributed in Jordan are within the common range known so far for these vaccines. Further studies are needed to include larger sample size and longer follow-up period to monitor possible serious and long-term SE of the vaccines.<\/jats:p>","DOI":"10.3390\/vaccines9060577","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T23:07:03Z","timestamp":1622588823000},"page":"577","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 Vaccines"],"prefix":"10.3390","volume":"9","author":[{"given":"Osama","family":"Abu-Hammad","sequence":"first","affiliation":[{"name":"College of Dentistry, Taibah University, Al Madinah Al Munawara 43353, Saudi Arabia"},{"name":"School of Dentistry, University of Jordan, Amman 11942, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1762-0575","authenticated-orcid":false,"given":"Hamza","family":"Alduraidi","sequence":"additional","affiliation":[{"name":"School of Nursing, University of Jordan, Amman 11942, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaden","family":"Abu-Hammad","sequence":"additional","affiliation":[{"name":"Comprehensive Amman Healthcare Center, Amman 11192, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4041-4083","authenticated-orcid":false,"given":"Ahmed","family":"Alnazzawi","sequence":"additional","affiliation":[{"name":"College of Dentistry, Taibah University, Al Madinah Al Munawara 43353, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamzah","family":"Babkair","sequence":"additional","affiliation":[{"name":"College of Dentistry, Taibah University, Al Madinah Al Munawara 43353, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdalla","family":"Abu-Hammad","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Jordan, Amman 11942, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Nourwali","sequence":"additional","affiliation":[{"name":"College of Dentistry, Taibah University, Al Madinah Al Munawara 43353, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Qasem","sequence":"additional","affiliation":[{"name":"University of Jordan Hospital, Amman 11942, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najla","family":"Dar-Odeh","sequence":"additional","affiliation":[{"name":"College of Dentistry, Taibah University, Al Madinah Al Munawara 43353, Saudi Arabia"},{"name":"School of Dentistry, University of Jordan, Amman 11942, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4269\/ajtmh.20-0654","article-title":"Threat of COVID-19 Vaccine Hesitancy in Pakistan: The Need for Measures to Neutralize Misleading Narratives","volume":"103","author":"Khan","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Abu-Hammad, O., Alnazzawi, A., Borzangy, S.S., Abu-Hammad, A., Fayad, M., Saadaledin, S., Abu-Hammad, S., and Dar-Odeh, N. (2020). Factors Influencing Global Variations in COVID-19 Cases and Fatalities; A Review. Healthcare, 8.","DOI":"10.3390\/healthcare8030216"},{"key":"ref_3","unstructured":"(2021, March 24). WM. Available online: https:\/\/www.worldometers.info\/coronavirus\/#countries."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): A single-blind, randomised, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy","year":"2021","journal-title":"Lancet"},{"key":"ref_5","unstructured":"(2021, April 17). CDC, Available online: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/expect\/after.html."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Dar-Odeh, N., Babkair, H., Abu-Hammad, S., Borzangy, S., Abu-Hammad, A., and Abu-Hammad, O. (2020). COVID-19: Present and Future Challenges for Dental Practice. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17093151"},{"key":"ref_7","unstructured":"(2021, April 17). MHRA, Available online: https:\/\/www.gov.uk\/government\/publications\/coronavirus-covid-19-vaccine-adverse-reactions."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.15585\/mmwr.mm7008e3","article-title":"First Month of COVID-19 Vaccine Safety Monitoring\u2014United States, December 14, 2020-January 13, 2021","volume":"70","author":"Gee","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(21)00085-4","article-title":"The European Medicines Agency\u2019s EU conditional marketing authorisations for COVID-19 vaccines","volume":"397","author":"Cavaleri","year":"2021","journal-title":"Lancet"},{"key":"ref_10","unstructured":"(2021, April 15). Rheuters. Available online: https:\/\/graphics.reuters.com\/world-coronavirus-tracker-and-maps\/countries-and-territories\/jordan\/."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"n912","DOI":"10.1136\/bmj.n912","article-title":"What do we know about China\u2019s covid-19 vaccines?","volume":"373","author":"Baraniuk","year":"2021","journal-title":"BMJ"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Rodriguez-Coira, J., and Sokolowska, M. (2020). SARS-CoV-2 candidate vaccines\u2014Composition, mechanisms of action and stages of clinical development. Allergy.","DOI":"10.1111\/all.14714"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","article-title":"Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults","volume":"383","author":"Anderson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_14","first-page":"1663","article-title":"COVID-19 vaccines: Comparison of biological, pharmacological characteristics and adverse effects of Pfizer\/BioNTech and Moderna Vaccines","volume":"25","author":"Meo","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ashraf, M.U., Kim, Y., Kumar, S., Seo, D., Ashraf, M., and Bae, Y.-S. (2021). COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform. Vaccines, 9.","DOI":"10.3390\/vaccines9020171"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: A preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"n921","DOI":"10.1136\/bmj.n921","article-title":"Covid-19: How AstraZeneca lost the vaccine PR war","volume":"373","author":"Wise","year":"2021","journal-title":"BMJ"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e643","DOI":"10.1097\/SCS.0000000000006752","article-title":"Fallacies and Facts around COVID-19: The Multifaceted Infection","volume":"31","author":"Elsayed","year":"2020","journal-title":"J. Craniofac. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"n699","DOI":"10.1136\/bmj.n699","article-title":"Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots","volume":"372","author":"Wise","year":"2021","journal-title":"BMJ"},{"key":"ref_20","unstructured":"(2021, April 16). EMA. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/covid-19-vaccine-safety-update\/covid-19-vaccine-safety-update-vaxzevria-previously-covid-19-vaccine-astrazeneca-14-april-2021_en.pdf."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0140-6736(21)00762-5","article-title":"Thromboembolism and the Oxford-AstraZeneca COVID-19 vaccine: Side-effect or coincidence?","volume":"397","author":"Ostergaard","year":"2021","journal-title":"Lancet"},{"key":"ref_22","first-page":"185","article-title":"The Covid-19 Pandemic and Triggered Acute Myocardial Infarction among Non-Infected Individuals","volume":"7","author":"Hammoudeh","year":"2020","journal-title":"Int. J. Clin. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Abu-Hammad, S., Dar-Odeh, N., and Abu-Hammad, O. (2020). SARS-CoV-2 and oral ulcers: A causative agent or a predisposing factor?. Oral Dis.","DOI":"10.1111\/odi.13498"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/6\/577\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:09:46Z","timestamp":1760162986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/9\/6\/577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["vaccines9060577"],"URL":"https:\/\/doi.org\/10.3390\/vaccines9060577","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}